Raymond James Financial Services Advisors, Inc. - EVOKE PHARMA INC ownership

Back to all holdings Add to watchlist

EVOKE PHARMA INC's ticker is EVOK and the CUSIP is 30049G104. A total of 24 filers reported holding EVOKE PHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Raymond James Financial Services Advisors, Inc. ownership history of EVOKE PHARMA INC
ValueSharesWeighting
Q1 2022$54,000
-10.0%
108,5450.0%0.00%–
Q4 2021$60,000
-57.4%
108,5450.0%0.00%–
Q3 2021$141,000
-13.5%
108,545
-8.9%
0.00%–
Q2 2021$163,000–119,190–0.00%–
 Download
Other shareholders
EVOKE PHARMA INC shareholders Q3 2021
NameSharesValueWeighting ↓
Wambolt & Associates, LLC 33,165$29,0000.02%
STATE OF MICHIGAN RETIREMENT SYSTEM 400,000$344,0000.00%
A.R.T. Advisors, LLC 36,954$32,0000.00%
NORTHERN TRUST CORP 33,997$29,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 199,678$171,0000.00%
CITIGROUP INC 500$00.00%
MORGAN STANLEY 1,450$1,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 36,700$32,0000.00%
BlackRock Inc. 54,940$47,0000.00%
View complete list of EVOKE PHARMA INC shareholders